Repeated sampling and longitudinal monitoring of the development of CRC can ameliorate our understanding of the role of AFF4 in the physiological and pathological tissue transformation and exploring the specific stage of AFF4 in inhibiting colorectal cancer is crucial for the development of targeted therapies for CRC and other cancers. Here, AFF4 is linked to colorectal carcinoma.